The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was $9.85 for the day, down -2.09% from the previous closing price of $10.06. In other words, the price has decreased by -$2.09 from its previous closing price. On the day, 8.21 million shares were traded. BCRX stock price reached its highest trading level at $10.22 during the session, while it also had its lowest trading level at $9.77.
Ratios:
Our analysis of BCRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $20.
On February 25, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 2061112576 and an Enterprise Value of 2595313152. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.09. Its current Enterprise Value per Revenue stands at 5.155 whereas that against EBITDA is 69.258.
Stock Price History:
The Beta on a monthly basis for BCRX is 1.07, which has changed by 0.5224111 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, BCRX has reached a high of $11.11, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is 22.18%, while the 200-Day Moving Average is calculated to be 24.81%.
Shares Statistics:
BCRX traded an average of 4.63M shares per day over the past three months and 9517290 shares per day over the past ten days. A total of 209.21M shares are outstanding, with a floating share count of 197.52M. Insiders hold about 5.61% of the company’s shares, while institutions hold 81.41% stake in the company. Shares short for BCRX as of 1745971200 were 18295287 with a Short Ratio of 3.96, compared to 1743379200 on 20727104. Therefore, it implies a Short% of Shares Outstanding of 18295287 and a Short% of Float of 8.7799996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
